For the Inventor, By the Inventor

Enter assignee name

Copenhagen, Denmark

Nuevolution A/s

USPTO Granted Patents = 32

% Expired Patents = 12.5

CIPO Patents = 2

EPO Patents = 20

Trademarks = 2

Forward Citations = 277

Loading Chart...

Loading Chart...

63 inventors (with patents filed for the assignee):

Alex Haahr Gouliaev (27 out of 37 patents)

Thomas Franch (23 out of 26 patents)

Henrik Pedersen (16 out of 50 patents)

4. Anette Holtmann (14 out of 17 patents)

5. Jakob Felding (13 out of 31 patents)

6. Sanne Schrøder Glad (13 out of 14 patents)

7. Eva Kampmann Olsen (12 out of 14 patents)

8. Per-Ola Freskgard (11 out of 13 patents)

9. Christian Klarner Sams (11 out of 20 patents)

10. Mikkel Dybro Lundorf (10 out of 15 patents)

11. Thomas Thisted (9 out of 24 patents)

12. Ian Sarvary (8 out of 8 patents)

13. Luigi Piero Stasi (8 out of 8 patents)

14. Michael Anders Godskesen (8 out of 12 patents)

15. Gitte Nystrup Husemoen (6 out of 7 patents)

32 patents: Sort by Forward Citations

1. 12649918 - BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES (2026-06-09),

2. 12441704 - Compounds active towards nuclear receptors (2025-10-14),

3. 11965209 - Method for obtaining structural information concerning an encoded molecule and method for selecting compounds (2024-04-23),

4. 11780843 - Compounds active towards nuclear receptors (2023-10-10),

5. 11702652 - Enzymatic encoding methods for efficient synthesis of large libraries (2023-07-18),

6. 11685727 - Compounds active towards nuclear receptors (2023-06-27),

7. 11613532 - Compounds active towards nuclear receptors (2023-03-28),

8. 11447479 - Compounds active towards nuclear receptors (2022-09-20),

9. 11254681 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases (2022-02-22),

10. 11225655 - Bi-functional complexes and methods for making and using such complexes (2022-01-18),

11. 11118215 - Method for obtaining structural information concerning an encoded molecule and method for selecting compounds (2021-09-14),

12. 11001835 - Method for the synthesis of a bifunctional complex (2021-05-11),

13. 10752640 - Compounds active towards bromodomains (2020-08-25),

14. 10731151 - Method for synthesising templated molecules (2020-08-04),

15. 10689383 - Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases (2020-06-23),

Nuevolution A/S is a leading integrated drug discovery company based in Denmark. They specialize in small molecule drug discovery and offer innovative solutions for the development of new medicines. Nuevolution uses its proprietary technology platform and expertise to identify and optimize drug candidates for various therapeutic areas including cancer, autoimmune diseases, and metabolic disorders. With a focus on delivering high-quality drugs, Nuevolution collaborates with pharmaceutical companies and academic institutions worldwide. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

32 Patents

#13 in Copenhagen

#98 in Denmark

#20,635 in the World

Copenhagen, Denmark

Nuevolution A/s

Forward Citations = 277

63 inventors:

Alex Haahr Gouliaev (27 out of 37 patents)

Thomas Franch (23 out of 26 patents)

Henrik Pedersen (16 out of 50 patents)

4. Anette Holtmann (14 out of 17 patents)

5. Jakob Felding (13 out of 31 patents)

Please report any incorrect information to [email protected]

Loading…